Activin B regulates islet composition and islet mass but not whole body glucose homeostasis or insulin sensitivity

American Journal of Physiology - Endocrinology and Metabolism

Volumn 303, Issue 5, 2012, Pages

  Bonomi, Lara ^a   Brown, Melissa ^a   Ungerleider, Nathan ^a   Muse, Meghan ^a   Matzuk, Martin M ^b   Schneyer, Alan ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

cell; cell; Activin A; Follistatin; Myostatin

Indexed keywords

ACTIVIN A; ACTIVIN RECEPTOR LIKE KINASE 1; FOLLISTATIN; LYMPHOTOXIN; MYELOPID; MYOSTATIN; TRANSCRIPTION FACTOR PAX4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; CELL FUNCTION; CONTROLLED STUDY; GENOTYPE; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET ALPHA CELL; PRIORITY JOURNAL; WHOLE BODY COMPOSITION ANALYSIS;

ACTIVINS; AGING; ANIMALS; BLOOD GLUCOSE; CELL COUNT; FOLLISTATIN; GLUCAGON-SECRETING CELLS; HOMEOSTASIS; INHIBIN-BETA SUBUNITS; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOSTATIN; ORGAN SIZE; TISSUE CULTURE TECHNIQUES;

EID: 84865709927     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00177.2012     Document Type: Article

References (33)

1. Andersson O, Reissmann E, Ibanez CF. Growth differentiation factor 11 signals through the transforming growth factor-beta receptor ALK5 to regionalize the anterior-posterior axis. EMBO Rep 7: 831-837, 2006.
2. Artner I, Hang Y, Mazur M, Yamamoto T, Guo M, Lindner J, Magnuson MA, Stein R. MafA and MafB regulate genes critical to beta-cells in a unique temporal manner. Diabetes 59: 2530-2539, 2010.
3. Bertolino P, Holmberg R, Reissmann E, Andersson O, Berggren PO, Ibanez CF. Activin B receptor ALK7 is a negative regulator of pancreatic +/- cell function. Proc Natl Acad Sci USA 105: 7246-7251, 2008.
4. Brown CW, Houston-Hawkins DE, Woodruff TK, Matzuk MM. Insertion of Inhbb into the Inhba locus rescues the Inhba-null phenotype and reveals new activin functions. Nat Genet 25: 453-457, 2000.
5. Brown ML, Kimura F, Bonomi LM, Ungerleider NA, Schneyer AL. Differential synthesis and action of TGFss superfamily ligands in mouse and rat islets. Islets 3: 367-375, 2011.
6. Brun T, Franklin I, St-Onge L, Biason-Lauber A, Schoenle EJ, Wollheim CB, Gauthier BR. The diabetes-linked transcription factor PAX4 promotes (beta)-cell proliferation and survival in rat and human islets. J Cell Biol 167: 1123-1135, 2004.
7. Florio P, Luisi S, Marchetti P, Lupi R, Cobellis L, Falaschi C, Sugino H, Navalesi R, Genazzani AR, Petraglia F. Activin A stimulates insulin secretion in cultured human pancreatic islets. J Endocrinol Invest 23: 231-234, 2000.
8. Kim SK, Hebrok M, Li E, Oh SP, Schrewe H, Harmon EB, Lee JS, Melton DA. Activin receptor patterning of foregut organogenesis. Genes Dev 14: 1866-1871, 2000.
9. Kimura F, Sidis Y, Bonomi L, Xia Y, Schneyer A. The follistatin-288 isoform alone is sufficient for survival but not for normal fertility in mice. Endocrinology 151: 1310-1319, 2010.
10. Li L, Shen JJ, Bournat JC, Huang L, Chattopadhyay A, Li Z, Shaw C, Graham BH, Brown CW. Activin signaling: effects on body composition and mitochondrial energy metabolism. Endocrinology 150: 3521- 3529, 2009.
11. Lin HM, Lee JH, Yadav H, Kamaraju AK, Liu E, Zhigang D, Vieira A, Kim SJ, Collins H, Matschinsky F, Harlan DM, Roberts AB, Rane SG. Transforming growth factor-beta/Smad3 signaling regulates insulin gene transcription and pancreatic islet beta-cell function. J Biol Chem 284: 12246-12257, 2009.
12. Massague J. TGFbeta in cancer. Cell 134: 215-230, 2008.
13. Matzuk MM, Kumar TR, Vassilli A, Bickenbach RR, Roop DR, Jaenisch R, Bradley A. Functional analysis of activins during mammalian development. Nature 374: 354-356, 1995.
14. Mukherjee A, Sidis Y, Mahan A, Raher MJ, Xia Y, Rosen ED, Bloch KD, Thomas MK, Schneyer AL. FSTL3 deletion reveals roles for TGF-beta family ligands in glucose and fat homeostasis in adults. Proc Natl Acad Sci USA 104: 1348-1353, 2007.
15. Nishimura W, Kondo T, Salameh T, El K, I, Dodge R, Bonner-Weir S, Sharma A. A switch from MafB to MafA expression accompanies differentiation to pancreatic beta-cells. Dev Biol 293: 526-539, 2006.
16. Romano V, Raimondo D, Calvanese L, D'Auria G, Tramontano A, Falcigno L. Toward a better understanding of the interaction between TGF-beta family members and their ALK receptors. J Mol Model 2012 Feb 22 [Epub ahead of print] PMID: 22354277.
17. Schneyer AL, Sidis Y, Gulati A, Sun JL, Keutmann H, Krasney PA. Differential antagonism of activin, myostatin and growth and differentiation factor 11 by wild-type and mutant follistatin. Endocrinology 149: 4589-4595, 2008.
18. Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113: 685-700, 2003.
19. Shiozaki S, Tajima T, Zhang YQ, Furukawa M, Nakazato Y, Kojima I. Impaired differentiation of endocrine and exocrine cells of the pancreas in transgenic mouse expressing the truncated type II activin receptor. Biochim Biophys Acta 1450: 1-11, 1999.
20. Sidis Y, Mukherjee A, Keutmann H, Delbaere A, Sadatsuki M, Schneyer A. Biological activity of follistatin isoforms and follistatin like-3 are dependent on differential cell surface binding and specificity for activin, myostatin and BMP's. Endocrinology 147: 3586-3597, 2006.
21. Smart NG, Apelqvist AA, Gu X, Harmon EB, Topper JN, MacDonald RJ, Kim SK. Conditional expression of Smad7 in pancreatic beta cells disrupts TGF-beta signaling and induces reversible diabetes mellitus. PLoS Biol 4: e39, 2006.
22. Szabat M, Johnson JD, Piret JM. Reciprocal modulation of adult beta cell maturity by activin A and follistatin. Diabetologia 53: 1680-1689, 2010.
23. Szabat M, Pourghaderi P, Soukhatcheva G, Verchere CB, Warnock GL, Piret JM, Johnson JD. Kinetics and genomic profiling of adult human and mouse beta-cell maturation. Islets 3: 175-187, 2011.
24. Totsuka Y, Tabuchi M, Kojima I, Shibai H, Ogata E. A novel action of activin A: stimulation of insulin secretion in rat pancreatic islets. Biochem Biophys Res Commun 156: 335-339, 1988.
25. Tsuchida K, Nakatani M, Uezumi A, Murakami T, Cui X. Signal transduction pathway through activin receptors as a therapeutic target of musculoskeletal diseases and cancer. Endocr J 55: 11-21, 2008.
26. Tsuchida K, Nakatani M, Yamakawa N, Hashimoto O, Hasegawa Y, Sugino H. Activin isoforms signal through type I receptor serine/threonine kinase ALK7. Mol Cell Endocrinol 220: 59-65, 2004.
27. Ueda Y. Activin A increases Pax4 gene expression in pancreatic beta cell lines. FEBS Lett 480: 101-105, 2000.
28. Vale W, Rivier C, Hsueh A, Campen C, Meunier H, Bicsak T, Vaughan J, Corrigan A, Bardin W, Sawchenko P, Spiess J, Rivier J. Chemical and biological characterization of the inhibin family of protein hormones. Rec Prog Horm Res 44: 1-34, 1988.
29. Vassalli A, Matzuk MM, Gardner HA, Lee KF, Jaenisch R. Activin/ inhibin beta B subunit gene disruption leads to defects in eyelid development and female reproduction. Genes Dev 8: 414-427, 1994.
30. Welt C, Sidis Y, Keutmann H, Schneyer A. Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium. Exp Biol Med (Maywood) 227: 724-752, 2002.
31. Xia Y, Schneyer AL. The biology of activin: recent advances in structure, regulation and function. J Endocr 202: 1-12, 2009.
32. Yamaoka T, Idehara C, Yano M, Matsushita T, Yamada T, Ii S, Moritani M, Hata Ji Sugino H, Noji S, Itakura M. Hypoplasia of pancreatic islets in transgenic mice expressing activin receptor mutants. J Clin Invest 102: 294-301, 1998.
33. Yang YH, Szabat M, Bragagnini C, Kott K, Helgason CD, Hoffman BG, Johnson JD. Paracrine signalling loops in adult human and mouse pancreatic islets: netrins modulate beta cell apoptosis signalling via dependence receptors. Diabetologia 54: 828-842, 2011.